Change in moles linked to use of unlicensed “sun tan jab”BMJ 2009; 338 doi: http://dx.doi.org/10.1136/bmj.b277 (Published 28 January 2009) Cite this as: BMJ 2009;338:b277
- Ewan A Langan, Walport academic clinical fellow in dermatology1,
- Denise Ramlogan, consultant dermatologist2,
- Lynne A Jamieson, consultant dermatopathologist3,
- Lesley E Rhodes, professor of experimental dermatology1
- 1Dermatological Sciences, University of Manchester, Salford Royal NHS Foundation Trust, Salford M6 8HD
- 2Dermatology Centre, Salford Royal NHS Foundation Trust, Salford M6 8HD
- 3Department of Cellular Pathology, Salford Royal NHS Foundation Trust, Salford M6 8HD
We draw attention to a new factor complicating presentation and diagnosis of pigmented lesions1: unlicensed use of melanotropic peptides offered online as Melanotan I and II.
Two patients presented to our dermatology clinic with rapidly changing moles and a conspicuous tan, despite their sun reactive skin type I/II (sunburns easily, suntans poorly). They were both sunbed users. One, a woman of 42, reported two moles on her …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial